Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination

Mitsikostas, Dimos|||0000-0002-4691-3388; Caronna, Edoardo|||0000-0001-5525-0267; De Tommaso, Marina|||0000-0001-6567-5373; Deligianni, Christina I.|||0000-0002-6208-1059; Ekizoglu, Esme|||0000-0002-4904-9994; Bolay, Hayrunnisa|||0000-0002-3357-7733; Göbel, Carl Hartmut|||0000-0002-4283-6936; Kristoffersen, Espen Saxhaug|||0000-0002-8999-5424; Lampl, Christian|||0000-0003-1756-1181; Moro, Elena|||0000-0002-7968-5908; Pozo-Rosich, Patricia|||0000-0003-0796-4702; Sellner, Johann|||0000-0001-8749-5533; Terwindt, Gisela|||0000-0003-3140-6882; Irimia, Pablo|||0000-0002-7238-0036

Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination

The aim was to provide insights to the characteristics of headache in the context of COVID-19 on behalf of the Headache Scientific Panel and the Neuro-COVID-19 Task Force of the European Academy of Neurology (EAN) and the European Headache Federation (EHF). Following the Delphi method the Task Force...

Descripción completa

Detalles Bibliográficos
Autores:	Mitsikostas, Dimos\|\|\|0000-0002-4691-3388, Caronna, Edoardo\|\|\|0000-0001-5525-0267, De Tommaso, Marina\|\|\|0000-0001-6567-5373, Deligianni, Christina I.\|\|\|0000-0002-6208-1059, Ekizoglu, Esme\|\|\|0000-0002-4904-9994, Bolay, Hayrunnisa\|\|\|0000-0002-3357-7733, Göbel, Carl Hartmut\|\|\|0000-0002-4283-6936, Kristoffersen, Espen Saxhaug\|\|\|0000-0002-8999-5424, Lampl, Christian\|\|\|0000-0003-1756-1181, Moro, Elena\|\|\|0000-0002-7968-5908, Pozo-Rosich, Patricia\|\|\|0000-0003-0796-4702, Sellner, Johann\|\|\|0000-0001-8749-5533, Terwindt, Gisela\|\|\|0000-0003-3140-6882, Irimia, Pablo\|\|\|0000-0002-7238-0036
Tipo de recurso:	artículo
Fecha de publicación:	2024
País:	España
Institución:	Universitat Autònoma de Barcelona
Repositorio:	Dipòsit Digital de Documents de la UAB
Idioma:	inglés
OAI Identifier:	oai:ddd.uab.cat:319979
Acceso en línea:	https://ddd.uab.cat/record/319979 https://dx.doi.org/urn:doi:10.1111/ene.16251
Access Level:	acceso abierto
Palabra clave:	Chronic daily headache Headache Neurological disorders

id	ES_b0ba7ff4a7166f1f84523c8f2cf7d0f5
oai_identifier_str	oai:ddd.uab.cat:319979
network_acronym_str	ES
network_name_str	España
repository_id_str
spelling	Headaches and facial pain attributed to SARS-CoV-2 infection and vaccinationa systematic reviewMitsikostas, Dimos\|\|\|0000-0002-4691-3388Caronna, Edoardo\|\|\|0000-0001-5525-0267De Tommaso, Marina\|\|\|0000-0001-6567-5373Deligianni, Christina I.\|\|\|0000-0002-6208-1059Ekizoglu, Esme\|\|\|0000-0002-4904-9994Bolay, Hayrunnisa\|\|\|0000-0002-3357-7733Göbel, Carl Hartmut\|\|\|0000-0002-4283-6936Kristoffersen, Espen Saxhaug\|\|\|0000-0002-8999-5424Lampl, Christian\|\|\|0000-0003-1756-1181Moro, Elena\|\|\|0000-0002-7968-5908Pozo-Rosich, Patricia\|\|\|0000-0003-0796-4702Sellner, Johann\|\|\|0000-0001-8749-5533Terwindt, Gisela\|\|\|0000-0003-3140-6882Irimia, Pablo\|\|\|0000-0002-7238-0036Chronic daily headacheHeadacheNeurological disordersThe aim was to provide insights to the characteristics of headache in the context of COVID-19 on behalf of the Headache Scientific Panel and the Neuro-COVID-19 Task Force of the European Academy of Neurology (EAN) and the European Headache Federation (EHF). Following the Delphi method the Task Force identified six relevant questions and then conducted a systematic literature review to provide evidence-based answers and suggest specific diagnostic criteria. No data for facial pain were identified in the literature search. (1) Headache incidence during acute COVID-19 varies considerably, with higher prevalence rates in prospective compared to retrospective studies (28.9%-74.6% vs. 6.5%-34.0%). (2) Acute COVID-19 headache is usually bilateral or holocranial and often moderate to severe with throbbing pain quality lasting 2-14 days after first signs of COVID-19; photo-phonophobia, nausea, anosmia and ageusia are common associated features; persistent headache shares similar clinical characteristics. (3) Acute COVID-19 headache is presumably caused by immune-mediated mechanisms that activate the trigeminovascular system. (4) Headache occurs in 13.3%-76.9% following SARS-CoV-2 vaccination and occurs more often amongst women with a pre-existing primary headache; the risk of developing headache is higher with the adenoviral-vector-type vaccines than with other preparations. (5) Headache related to SARS-CoV-2 vaccination is mostly bilateral, and throbbing, pressing, jolting or stabbing. (6) No studies have been conducted investigating the underlying mechanism of headache attributed to SARS-CoV-2 vaccines. The results of this joint EAN/EHF initiative provide a framework for a better understanding of headache in the context of SARS-CoV-2 infection and vaccination. 22024-01-0120242024-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/319979https://dx.doi.org/urn:doi:10.1111/ene.16251reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:3199792026-06-06T12:50:31Z
dc.title.none.fl_str_mv	Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination a systematic review
title	Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination
spellingShingle	Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination Mitsikostas, Dimos\|\|\|0000-0002-4691-3388 Chronic daily headache Headache Neurological disorders
title_short	Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination
title_full	Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination
title_fullStr	Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination
title_full_unstemmed	Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination
title_sort	Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination
dc.creator.none.fl_str_mv	Mitsikostas, Dimos\|\|\|0000-0002-4691-3388 Caronna, Edoardo\|\|\|0000-0001-5525-0267 De Tommaso, Marina\|\|\|0000-0001-6567-5373 Deligianni, Christina I.\|\|\|0000-0002-6208-1059 Ekizoglu, Esme\|\|\|0000-0002-4904-9994 Bolay, Hayrunnisa\|\|\|0000-0002-3357-7733 Göbel, Carl Hartmut\|\|\|0000-0002-4283-6936 Kristoffersen, Espen Saxhaug\|\|\|0000-0002-8999-5424 Lampl, Christian\|\|\|0000-0003-1756-1181 Moro, Elena\|\|\|0000-0002-7968-5908 Pozo-Rosich, Patricia\|\|\|0000-0003-0796-4702 Sellner, Johann\|\|\|0000-0001-8749-5533 Terwindt, Gisela\|\|\|0000-0003-3140-6882 Irimia, Pablo\|\|\|0000-0002-7238-0036
author	Mitsikostas, Dimos\|\|\|0000-0002-4691-3388
author_facet	Mitsikostas, Dimos\|\|\|0000-0002-4691-3388 Caronna, Edoardo\|\|\|0000-0001-5525-0267 De Tommaso, Marina\|\|\|0000-0001-6567-5373 Deligianni, Christina I.\|\|\|0000-0002-6208-1059 Ekizoglu, Esme\|\|\|0000-0002-4904-9994 Bolay, Hayrunnisa\|\|\|0000-0002-3357-7733 Göbel, Carl Hartmut\|\|\|0000-0002-4283-6936 Kristoffersen, Espen Saxhaug\|\|\|0000-0002-8999-5424 Lampl, Christian\|\|\|0000-0003-1756-1181 Moro, Elena\|\|\|0000-0002-7968-5908 Pozo-Rosich, Patricia\|\|\|0000-0003-0796-4702 Sellner, Johann\|\|\|0000-0001-8749-5533 Terwindt, Gisela\|\|\|0000-0003-3140-6882 Irimia, Pablo\|\|\|0000-0002-7238-0036
author_role	author
author2	Caronna, Edoardo\|\|\|0000-0001-5525-0267 De Tommaso, Marina\|\|\|0000-0001-6567-5373 Deligianni, Christina I.\|\|\|0000-0002-6208-1059 Ekizoglu, Esme\|\|\|0000-0002-4904-9994 Bolay, Hayrunnisa\|\|\|0000-0002-3357-7733 Göbel, Carl Hartmut\|\|\|0000-0002-4283-6936 Kristoffersen, Espen Saxhaug\|\|\|0000-0002-8999-5424 Lampl, Christian\|\|\|0000-0003-1756-1181 Moro, Elena\|\|\|0000-0002-7968-5908 Pozo-Rosich, Patricia\|\|\|0000-0003-0796-4702 Sellner, Johann\|\|\|0000-0001-8749-5533 Terwindt, Gisela\|\|\|0000-0003-3140-6882 Irimia, Pablo\|\|\|0000-0002-7238-0036
author2_role	author author author author author author author author author author author author author
dc.subject.none.fl_str_mv	Chronic daily headache Headache Neurological disorders
topic	Chronic daily headache Headache Neurological disorders
description	The aim was to provide insights to the characteristics of headache in the context of COVID-19 on behalf of the Headache Scientific Panel and the Neuro-COVID-19 Task Force of the European Academy of Neurology (EAN) and the European Headache Federation (EHF). Following the Delphi method the Task Force identified six relevant questions and then conducted a systematic literature review to provide evidence-based answers and suggest specific diagnostic criteria. No data for facial pain were identified in the literature search. (1) Headache incidence during acute COVID-19 varies considerably, with higher prevalence rates in prospective compared to retrospective studies (28.9%-74.6% vs. 6.5%-34.0%). (2) Acute COVID-19 headache is usually bilateral or holocranial and often moderate to severe with throbbing pain quality lasting 2-14 days after first signs of COVID-19; photo-phonophobia, nausea, anosmia and ageusia are common associated features; persistent headache shares similar clinical characteristics. (3) Acute COVID-19 headache is presumably caused by immune-mediated mechanisms that activate the trigeminovascular system. (4) Headache occurs in 13.3%-76.9% following SARS-CoV-2 vaccination and occurs more often amongst women with a pre-existing primary headache; the risk of developing headache is higher with the adenoviral-vector-type vaccines than with other preparations. (5) Headache related to SARS-CoV-2 vaccination is mostly bilateral, and throbbing, pressing, jolting or stabbing. (6) No studies have been conducted investigating the underlying mechanism of headache attributed to SARS-CoV-2 vaccines. The results of this joint EAN/EHF initiative provide a framework for a better understanding of headache in the context of SARS-CoV-2 infection and vaccination.
publishDate	2024
dc.date.none.fl_str_mv	2 2024-01-01 2024 2024-01-01
dc.type.none.fl_str_mv	Article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv	info:eu-repo/semantics/article
format	article
dc.identifier.none.fl_str_mv	https://ddd.uab.cat/record/319979 https://dx.doi.org/urn:doi:10.1111/ene.16251
url	https://ddd.uab.cat/record/319979 https://dx.doi.org/urn:doi:10.1111/ene.16251
dc.language.none.fl_str_mv	Inglés eng
language_invalid_str_mv	Inglés
language	eng
dc.rights.none.fl_str_mv	open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv	info:eu-repo/semantics/openAccess
rights_invalid_str_mv	open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv	openAccess
dc.format.none.fl_str_mv	application/pdf
dc.source.none.fl_str_mv	reponame:Dipòsit Digital de Documents de la UAB instname:Universitat Autònoma de Barcelona
instname_str	Universitat Autònoma de Barcelona
reponame_str	Dipòsit Digital de Documents de la UAB
collection	Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_	1869416851152306176
score	15,811543

Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination

Similares en LA Referencia